Long-term administration of multikinase inhibitors is a potential risk factor for atherosclerosis in patients with thyroid cancer
{{output}}
Introduction: Vascular endothelial growth factor inhibitors are key drugs for cancer treatment as they inhibit angiogenesis. However, they also promote atherosclerosis in normal vessels, though the clinical significance of this p... ...
